A Study of Suitable Amounts of Rehabilitation Training for Patients Aged 75 Years or Above with Cerebral Infarction in Relation to Functional Improvements in Convalescent Rehabilitation Wards
- VernacularTitle:75歳以上の高齢脳梗塞患者に対するリハビリテーション実施量の検討 ―回復期リハビリテーション病棟での機能改善と関連して―
- Author:
Junya HIRATA
1
;
Masaru UMEDA
2
;
Kyoko TANAKA
3
;
Makoto ZUKERAN
3
;
Masaki GOTO
3
;
Keiko INOUE
4
;
Shunji NISHIO
1
Author Information
- Keywords: elderly; cerebral infarction; convalescent rehabilitation; Functional Independence Measure
- From:The Japanese Journal of Rehabilitation Medicine 2020;57(8):749-756
- CountryJapan
- Language:Japanese
- Abstract: It remains unclear how much rehabilitation training is suitable for stroke patients aged ≥ 75 years. To investigate this, especially in convalescent rehabilitation wards, we studied 65 patients (28, ≦ 74 years;37 ≧ 75 years) with cerebral infarction hospitalized in the acute care ward and then in a convalescent rehabilitation ward. From their medical records, we collected data regarding the length of their hospital stay, total amount of rehabilitation training, and activities of daily living evaluated using the total scores of the functional independent measure (FIM) measured on admission to the acute care and convalescent rehabilitation wards, respectively. From these data, we calculated the absolute functional gain, relative functional gain, and average amount of rehabilitation training per day. The correlation of each item and age was analyzed. Items that significantly correlated with age were compared between ≦ 74 and ≧ 75 years age groups. As a result, the absolute functional gain and average amount of rehabilitation training per day were not significantly different between groups. The relative functional gain was significantly lower in the ≧ 75 years group than in the ≦ 74 years group. The total FIM scores at discharge showed a positive correlation with the amount of rehabilitation training in patients aged ≧ 75 years. We believe that a large amount of rehabilitation training is beneficial for patients aged ≧ 75 years with cerebral infarction.